Ciclosporin/rituximabLack of efficacy in idiopathic focal and segmental glomerulosclerosis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1813卷 / 1期

关键词：

D O I：

10.1007/s40278-020-80837-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：80 / 80

相关论文

共 50 条

[1] Ciclosporin/rituximabLack of efficacy: case report
Reactions Weekly, 2023, 1960 (1) : 138 - 138
[2] IDIOPATHIC FOCAL SEGMENTAL GLOMERULOSCLEROSIS RESISTANT TO CICLOSPORIN-A THERAPY
DAKSHINAMURTY, KV
HARIHARAN, S
DATE, A
KIRUBAKARAN, MG
NEPHRON, 1988, 48 (04): : 340 - 340
[3] Ciclosporin/tacrolimusCalcineurin inhibitor-associated arteriopathy and focal segmental glomerulosclerosis: case report
Reactions Weekly, 2012, 1417 (1) : 17 - 17
[4] Idiopathic focal segmental glomerulosclerosis
Schnaper, HW
SEMINARS IN NEPHROLOGY, 2003, 23 (02) : 183 - 193
[5] Idiopathic Focal Segmental Glomerulosclerosis
Naseri, Mitra
Madani, Abbas
Attaii, Nematolah
Naseri, Homa
INDIAN PEDIATRICS, 2010, 47 (06) : 507 - 510
[6] Idiopathic focal segmental glomerulosclerosis
Mitra Naseri
Abbas Madani
Nematolah Attaii
Homa Naseri
Indian Pediatrics, 2010, 47 : 507 - 510
[7] PembrolizumabHypothyroidism and focal segmental glomerulosclerosis: case report
Reactions Weekly, 2021, 1884 (1) : 356 - 356
[8] ElasomeranCollapsing focal segmental glomerulosclerosis: case report
Reactions Weekly, 2022, 1936 (1) : 208 - 208
[9] Ciclosporin/rituximabLack of efficacy and COVID-19: case report
Reactions Weekly, 2020, 1833 (1) : 121 - 121
[10] Multiple drugsCollapsing focal segmental glomerulosclerosis (cFSGS) and lack of efficacy: case report
Reactions Weekly, 2024, 2036 (1) : 295 - 295

← 1 2 3 4 5 →